<DOC>
	<DOCNO>NCT02337608</DOCNO>
	<brief_summary>- Approximately 60 patient suffer moderate severe ulcerative colitis evaluate improvement disease activity ( efficacy ) take GLPG1205 match placebo daily 12 week addition stable background treatment . - During course study , patient also examine side effect may occur ( safety tolerability ) , amount GLPG1205 present blood ( Pharmacokinetics ) well effect GLPG1205 disease- mechanism action-related parameter ( Pharmacodynamics ) blood , stool colonic biopsy determine .</brief_summary>
	<brief_title>Efficacy Safety GLPG1205 Subjects With Active Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Male female subject 18 75 year Documented history UC Presence active UC minimum period 14 day prior screen spread beyond rectum , Mayo score ≥ 6 rectal bleed score ≥ 1 endoscopy score ≥ 2 Absence infectious colitis Tumor necrosis factor alpha ( TNFα ) inhibitornaive subject fail least 1 prior conventional therapy Continuation concurrent treatment oral steroid ( ≤30 mg prednisolone eq/day ) , immunosuppressants 5aminosalicylates stable dose allow Female subject must negative blood pregnancy test , unless surgically sterile , hysterectomy , postmenopausal least 1 year Subjects use highly effective contraceptive method History sensitivity component study drug , history drug allergy Any concurrent illness , condition , disability , clinically significant abnormality , investigator 's opinion , represent safety risk subject 's participation , may affect interpretation data , may prevent subject safely complete assessment History significant psychological , neurologic , hepatic , renal , endocrine , cardiovascular , GI ( UC ) , pulmonary , metabolic disease History active infection require intravenous antibiotic within past 4 week prior screen . History malignancy within past 5 year ; presence history intestinal malignancy History bowel surgery within 6 month prior screen ; history colon resection &lt; 30 cm colon remain Suspicion Crohn 's disease , indeterminate colitis , microscopic colitis , ischemic colitis , diverticular diseaseassociated colitis , radiationinduced colitis Subject receive nonpermitted UC therapy within specify timeframes , depend medication , state protocol Subject pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>moderate severe ulcerative colitis</keyword>
	<keyword>GLPG1205</keyword>
</DOC>